Laser Assisted Therapies and Immunotherapies for Oncology
Assisted Laser Therapies and Immunotherapies for Oncology
Following the success of the PhoS-Istos European project, MBD Texinov will propose a commercial solution for the treatment of actinic keratoses by PDT.
This phase II clinical trial aims to treat actinic keratosis with photodynamic therapy.
The French regulatory agencies (ANSM and CPP) authorize our clinical trial on the photodynamic treatment of the Paget's disease.
Evaluation of the PHOS-ISTOS® project completed, with a very favorable opinion from the European Commission
The first patient with Paget's disease has been treated by the PAGETEX clinical protocol.
Prof. Mortier presented this technology on Europe 1 radio